An additional peril of pathologic complete response
- PMID: 40441489
- DOI: 10.1016/j.radonc.2025.110962
An additional peril of pathologic complete response
Abstract
Pathological complete response (pCR) has been shown to predict long-term outcomes in breast cancer patients undergoing primary systemic therapy in aggressive early breast cancer. Herein we discuss the caveats of determining pCR, and data needed to tailor breast cancer radiation after pCR.
Keywords: Breast cancer; Neoadjuvant; Pathological complete response; Primary systemic therapy; Radiation.
Copyright © 2025 The Authors. Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical